ASTA Follows Up with FDA on Saffron Holds and Rejections
ASTA met with U.S. Food and Drug Administration (FDA) officials regarding the increased inspection and detention of saffron shipments for economically motivated adulteration.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
FDA Issues Warning Letter to Manufacturer of Apple Cinnamon Fruit Puree Products Containing Elevated Levels of Lead and Chromium
News & Updates
Industry News
8/20/2024
This is an article from the August 20, 2024, FYI ASTA newsletter.
Cosmed Group Inc. Files for Bankruptcy
News & Updates
Industry News
11/26/2024
This is an article from the November 26, 2024, FYI ASTA newsletter.
